SPI Infoamtion

このレポートは章ごとの個別販売も行っておりますのでお問い合わせ下さい。
※全てPDFでの販売となります。

Title / Chapter Name	Pages	Price
Biotechnologies for Medical Applications: Global Markets	223	$4,850
Chapter- 1: INTRODUCTION -- Complimentary	5	$0
Chapter-2: SUMMARY	2	$150
Chapter-3: OVERVIEW	11	$359
Chapter-4: AMINO ACIDS	7	$228
Chapter-5: ENZYMES	14	$457
Chapter-6: POLYCLONAL ANTIBODIES	18	$587
Chapter-7: MONOCLONAL ANTIBODIES	22	$718
Chapter-8: STEM CELLS	14	$457
Chapter-9: BOTANICALS	18	$587
Chapter-10: VACCINES	11	$359
Chapter-11: NUCLEIC ACIDS	16	$522
Chapter-12: MICROORGANISM	6	$196
Chapter-13: NON-STEM CELLS/TISSUES	12	$391
Chapter-14: BIOPOLYMERS	13	$424
Chapter-15: OTHER BIOMATERIALS	10	$326
Chapter-16: BIOELECTRONICS	11	$359
Chapter-17: COMPANY PROFILES	33	$1,077

Chapter- 1: INTRODUCTION
STUDY BACKGROUND
STUDY GOALS AND OBJECTIVES
INTENDED AUDIENCE
SCOPE OF REPORT
INFORMATION SOURCES AND METHODOLOGY
ANALYST CREDENTIALS
RELATED BCC RESEARCH REPORTS
BCC ONLINE SERVICES
DISCLAIMER

Chapter-2: SUMMARY
SUMMARY TABLE MEDICAL MARKET FOR BIOTECHNOLOGIES, BY TYPE OF END USE, 2009 THROUGH 2015 ($ BILLION)
SUMMARY FIGURE TRENDS IN MEDICAL MARKET FOR BIOTECHNOLOGIES BY TYPE OF END-USE, 2009-2015 (%)

Chapter-3: OVERVIEW
DEFINITIONS
GENERAL DESCRIPTION OF BIOTECHNOLOGIES USED IN MEDICAL APPLICATIONS
TABLE 1 MAJOR TYPES OF BIOTECHNOLOGIES USED IN MEDICAL APPLICATIONS
AMINO ACIDS
ENZYMES
POLYCLONAL ANTIBODIES
MONOCLONAL ANTIBODIES
STEM CELLS
BOTANICALS
VACCINES
NUCLEIC ACIDS
MICROORGANISMS
BIOPOLYMERS
NON-STEM CELLS/TISSUES
OTHER BIOMATERIALS
BIOELECTRONICS
OVERALL MARKET SIZE AND SEGMENTATION
MARKET SIZE
FIGURE 1 TRENDS IN MEDICAL MARKET FOR BIOTECHNOLOGIES, 2009-2015 ($ MILLION)
BIOTECHNOLOGY SEGMENTS
TABLE 2 MEDICAL MARKET FOR BIOTECHNOLOGIES, BY TYPE OF TECHNOLOGY, 2009-2015 ($ BILLION)
FIGURE 2 TRENDS IN MEDICAL MARKET FOR BIOTECHNOLOGIES BY TYPE OF TECHNOLOGY, 2009-2015 (%)
MAJOR GEOGRAPHICAL MARKETS
TABLE 3 MEDICAL MARKET FOR BIOTECHNOLOGIES, BY COUNTRY/REGION, THROUGH 2015 ($ MILLIONS)
FIGURE 3 TRENDS IN MEDICAL MARKET FOR BIOTECHNOLOGIES BY COUNTRY/REGION, 2009-2015 (%)

Chapter-4: AMINO ACIDS
GENERAL DESCRIPTION AND PROPERTIES
AMINO ACID APPLICATIONS
THERAPEUTIC APPLICATIONS
TABLE 4 MAJOR THERAPEUTIC APPLICATIONS OF AMINO ACIDS
Active Ingredients
Intermediates
Non-active Ingredients
BIORESEARCH AND DRUG DELIVERY
RECENT DEVELOPMENTS IN AMINO ACIDS
NEW AMINO ACID FERMENTATION TECHNOLOGY
AMINO ACID SUPPLIERS AND MARKET SHARES
TABLE 5 MAJOR SUPPLIERS OF AMINO ACIDS
MARKET SIZE AND SEGMENTATION, 2009 THROUGH 2015
TABLE 6 GLOBAL MARKET FOR AMINO ACIDS USED IN BIOTECHNOLOGY APPLICATIONS, THROUGH 2015 ($ BILLION)
TABLE 7 GLOBAL MARKET FOR AMINO ACIDS BY GEOGRAPHICAL SEGMENT, THROUGH 2015 ($ BILLION)
FIGURE 4 GLOBAL MARKET FOR AMINO ACIDS SEGMENTED BY GEOGRAPHY, 2009-2015 (%)

Chapter-5: ENZYMES
GENERAL DESCRIPTION AND PROPERTIES
APPLICATIONS
THERAPEUTIC APPLICATIONS
TABLE 8 ENZYMES BY THERAPEUTIC APPLICATION
Agalsidase Beta
Alglucosidase Alfa
Asparaginase
Collagenase
DNAse
Factors VII and IX
Glucocerebrosidase
Pancrelipase
Superoxide Dismutase
Tissue Plasminogen Activator
Urokinase
DIAGNOSTIC AND ANALYTICAL TESTS
TABLE 9 ENZYME DIAGNOSTIC AND ANALYTIC TESTS BY TARGET ANALYTE
Choline Oxidase
Creatininase
Cholesterol Esterase
Glucose Oxidase
Glutamine Oxidase
Lactate Monoxygenase
Urease
DRUG MANUFACTURING
RECENT TECHNOLOGY DEVELOPMENTS
‘DESIGNER ENZYMES’ CREATED BY CHEMISTS AT UCLA, UNIVERSITY OF WASHINGTON
NEW VARIANTS OF REVERSE TRANSCRIPTASE ENZYME FROM HIV TO BE USED IN HIGH-THROUGHPUT PROTEIN CRYSTALLOGRAPHY TO ENHANCE STRUCTURE BASED DRUG DESIGN
DISCOVERY OF TUBERCULOSIS BACTERIUM ENZYME
ENZYME INDUSTRY STRUCTURE AND MARKET SHARES
TABLE 10 MAJOR SUPPLIERS OF ENZYMES FOR MEDICAL APPLICATIONS
MARKET SIZE AND SEGMENTATION, 2009 THROUGH 2015
TABLE 11 GLOBAL MARKET FOR ENZYMES BY TYPE OF MEDICAL APPLICATION, THROUGH 2015 ($ BILLION)
FIGURE 5 GLOBAL MARKET FOR ENZYMES BY APPLICATION SEGMENT, 2009-2015 (%)
TABLE 12 GLOBAL MARKET FOR THERAPEUTIC ENZYMES BY MEDICAL APPLICATION, THROUGH 2015 ($ BILLION)
FIGURE 6 GLOBAL MARKET FOR THERAPEUTIC ENZYMES BY APPLICATION SEGMENT, 2009-2015 (%)
TABLE 13 GLOBAL MARKET FOR ENZYMES BY GEOGRAPHICAL SEGMENT, THROUGH 2015 ($ BILLION)
FIGURE 7 GLOBAL MARKET FOR ENZYMES SEGMENTED BY GEOGRAPHY, 2009-2015 (%)

Chapter-6: POLYCLONAL ANTIBODIES
GENERAL DESCRIPTION AND PROPERTIES
IMMUNOGLOBULINS
Normal Immunoglobulins
Hyperimmune Globulins
RECOMBINANT POLYCLONAL ANTIBODIES
APPLICATIONS
THERAPEUTIC APPLICATIONS
Immune Disorders
TABLE 14 IMMUNE DISORDERS TREATED WITH IMMUNOGLOBULIN REPLACEMENT THERAPY
Viral and Bacterial Infections
Immunosuppression
Venomous Bites and Stings
Neurological Disorders
Rh Incompatibility
DIAGNOSTIC APPLICATIONS
RESEARCH APPLICATIONS
ANTIBODY INDUSTRY STRUCTURE AND MARKET SHARES
TABLE 15 COMMERCIAL SUPPLIERS OF POLYCLONAL ANTIBODIES FOR MEDICAL APPLICATIONS
FIGURE 8 POLYCLONAL ANTIBODY MARKET SHARES (%)
RECENT DEVELOPMENTS IN POLYCLONAL ANTIBODIES
RECOMBINANT POLYCLONAL ANTIBODIES
MARKET SIZE AND SEGMENTATION, 2009 THROUGH 2015
TABLE 16 GLOBAL MARKET FOR POLYCLONAL ANTIBODIES BY APPLICATION SEGMENT, THROUGH 2015 ($ BILLION)
FIGURE 9 GLOBAL MARKET FOR POLYCLONAL ANTIBODIES BY APPLICATION SEGMENT, 2009-2015 (%)
TABLE 17 GLOBAL MARKET FOR THERAEPUTIC POLYCLONAL ANTIBODIES BY TYPE OF ANTIBODY, THROUGH 2015 ($ BILLION)
FIGURE 10 GLOBAL MARKET FOR THERAPEUTIC POLYCLONAL ANTIBODIES SEGMENTED BY TYPE OF ANTIBODY, 2009-2015 (%)
TABLE 18 GLOBAL MARKET FOR THERAPEUTIC POLYCLONAL ANTIBODIES BY TYPE OF APPLICATION, THROUGH 2015 ($ BILLION)
FIGURE 11 GLOBAL MARKET FOR THERAPEUTIC POLYCLONAL ANTIBODIES BY APPLICATION SEGMENT, 2009-2015 (%)
TABLE 19 GLOBAL MARKET FOR POLYCLONAL ANTIBODIES BY GEOGRAPHICAL SEGMENT, THROUGH 2015 ($ BILLION)
FIGURE 12 GLOBAL MARKET FOR POLYCLONAL ANTIBODIES SEGMENTED BY GEOGRAPHY, 2009-2015 (%)

Chapter-7: MONOCLONAL ANTIBODIES
GENERAL DESCRIPTION AND PROPERTIES
APPLICATIONS
THERAPEUTIC APPLICATIONS
Cancer Drugs
TABLE 20 MONOCLONAL ANTIBODIES USED TO TREAT CANCER
Anti-inflammatories
TABLE 21 MONOCLONAL ANTIBODY-BASED ANTI-INFLAMMATORY DRUGS
Anti-Infection Drugs
TABLE 22 MONOCLONAL ANTIBODY-BASED ANTI-INFECTION DRUGS
Immunosuppressive Drugs
TABLE 23 MONOCLONAL ANTIBODY-BASED IMMUNOSUPPRESSIVE DRUGS
Other Therapeutic Applications
TABLE 24 OTHER ANTIBODY-BASED DRUGS
DIAGNOSTIC APPLICATIONS
MEDICAL RESEARCH
TABLE 25 MONOCLONAL ANTIBODY APPLICATIONS IN MEDICAL RESEARCH
DRUG MANUFACTURING
RECENT DEVELOPMENTS IN MONOCLONAL TECHNOLOGY
DEVELOPMENT OF NEW MONOCLONAL ANTIBODIES
GENOMICS-BASED APPROACHES TO MONOCLONAL ANTIBODY IDENTIFICATION
FASTER PRODUCTION OF MONOCLONAL ANTIBODIES
MONOCLONAL ANTIBODY INDUSTRY STRUCTURE AND MARKET SHARES
TABLE 26 MAJOR SUPPLIERS OF MONOCLONAL ANTIBODIES
FIGURE 13 MAJOR THERAPEUTIC MONOCLONAL ANTIBODY MARKET SHARES, 2008 (% OF TOTAL THERAPEUTIC ANTIBODY)
MARKET SIZE AND SEGMENTATION, 2009 THROUGH 2015
TABLE 27 GLOBAL MARKET FOR MONOCLONAL ANTIBODIES BY APPLICATION SEGMENT, THROUGH 2015 ($ BILLION)
FIGURE 14 GLOBAL MARKET FOR MONOCLONAL ANTIBODIES BY APPLICATION SEGMENT, 2009-2015 (%)
TABLE 28 GLOBAL MARKET FOR THERAPEUTIC MONOCLONAL ANTIBODIES BY TYPE OF APPLICATION, THROUGH 2015 ($ BILLION)
FIGURE 15 GLOBAL MARKET FOR THERAPEUTIC MONOCLONAL ANTIBODIES BY APPLICATION SEGMENT, 2009-2015 (%)
TABLE 29 GLOBAL MARKET FOR THERAPEUTIC MONOCLONAL ANTIBODIES BY TYPE OF ANTIBODY, THROUGH 2015 ($ BILLION)
FIGURE 16 GLOBAL MARKET FOR MONOCLONAL ANTIBODIES SEGMENTED BY TYPE OF ANTIBODY, 2009-2015 (%)
TABLE 30 GLOBAL MARKET FOR MONOCLONAL ANTIBODIES BY GEOGRAPHICAL SEGMENT, THROUGH 2015 ($ BILLION)
FIGURE 17 GLOBAL MARKET FOR MONOCLONAL ANTIBODIES SEGMENTED BY GEOGRAPHY, 2009-2015 (%)

Chapter-8: STEM CELLS
GENERAL DESCRIPTION AND PROPERTIES
APPLICATIONS
THERAPY
Bone Marrow Transplants
Bone Substitutes
Other Cell-Based Therapies
Research
Disease Modeling
Drug Discovery
Personalized Medicine
RECENT TECHNOLOGY DEVELOPMENTS
NEW WAY FOUND TO CONVERT ADULT STEM CELLS TO IPSCS
TISSUE REGENERATION PROMOTED BY ENHANCED STEM CELLS
STEM CELL GROWTH, REGENERATION PROMOTED BY NEWLY IDENTIFIED GROWTH FACTOR
THERAPEUTIC CELLS DERIVED FROM IPS CELLS DISPLAY EARLY AGING
AMNIOTIC STEM CELLS CAN ACQUIRE PROPERTIES OF EMBRYONIC STEM CELLS
INDUSTRY STRUCTURE AND MARKET SHARES
TABLE 31 DEVELOPERS AND SUPPLIERS OF STEM CELL APPLICATIONS
MARKET SIZE AND SEGMENTATION, 2009 THROUGH 2015
TABLE 32 GLOBAL STEM CELL MARKET BY TYPE OF APPLICATION, THROUGH 2015 ($ BILLION)
FIGURE 18 GLOBAL STEM CELL MARKET APPLICATION SEGMENTS, 2009-2015 (%)
TABLE 33 GLOBAL THERAPEUTIC MARKET FOR STEM CELLS BY APPLICATION, THROUGH 2015 ($ BILLION)
TABLE 34 GLOBAL STEM CELL MARKET BY GEOGRAPHICAL MARKET, THROUGH 2015 ($ BILLION)
FIGURE 19 GLOBAL STEM CELL MARKET GEOGRAPHICAL SEGMENTS, 2009-2015 (%)

Chapter-9: BOTANICALS
GENERAL DESCRIPTION AND PROPERTIES
WHAT IS A BOTANICAL?
PROPERTIES OF BOTANICALS
Alkaloids
Terpenes
Glycosides
Other Plant Substances
APPLICATIONS
THERAPEUTIC APPLICATIONS
TABLE 35 THERAPEUTIC APPLICATIONS OF PLANT DERIVED DRUGS
Plant-manufactured Drugs
Plantigens
Plantibodies
Hormones
INDUSTRY STRUCTURE AND MARKET SHARES
PRIMARY PRODUCERS
Commercial Growers
Wild-Collectors
BULK PROCESSORS
TABLE 36 MAJOR BULK PRODUCERS OF PLANT-BASED MEDICINALS
FORMULATORS
TABLE 37 MAJOR FORMULATORS OF PLANT-DERIVED DRUGS
SALES AND MARKET SHARES
TABLE 38 PLANT-DERIVED DRUG SALES BY LEADING DRUG COMPANIES, 2008
TABLE 39 LEADING PLANT-DERIVED DRUG COMPANIES’ ESTIMATED MARKET SHARES, 2008 ($ BILLION/%)
FIGURE 20 LEADING PLANT-DERIVED DRUG COMPANIES’ ESTIMATED MARKET SHARES, 2008 (%)
MARKET SIZE AND SEGMENTATION, 2009 THROUGH 2015
TABLE 40 GLOBAL MARKET FOR PLANT-DERIVED DRUGS BY MEDICAL APPLICATION, THROUGH 2015 ($ BILLION)
FIGURE 21 GLOBAL MARKET FOR PLANT-DERIVED DRUGS BY APPLICATION SEGMENT, 2009-2015 (%)
TABLE 41 GLOBAL MARKET FOR PLANT-DERIVED DRUGS BY GEOGRAPHICAL SEGMENT, THROUGH 2015 ($ BILLION)
FIGURE 22 GLOBAL MARKET FOR PLANT-DERIVED DRUGS SEGMENTED BY GEOGRAPHY, 2009-2015 (%)

Chapter-10: VACCINES
GENERAL DESCRIPTION AND PROPERTIES
APPLICATIONS
TABLE 42 HUMAN VACCINES
RECENT DEVELOPMENTS
DNA VACCINES
CANCER VACCINES
VACCINES FOR SUBSTANCE ADDICTION
NEW VACCINE DELIVERY SYSTEMS
INDUSTRY STRUCTURE
TABLE 43 MAJOR VACCINE SUPPLIERS
FIGURE 23 LEADING VACCINE SUPPLIERS’ MARKET SHARES, 2008 (%)
TABLE 44 OTHER COMPANIES DEVELOPING NEW VACCINES
MARKETS
TABLE 45 GLOBAL MARKET FOR HUMAN VACCINES BY THERAPEUTIC APPLICATION, THROUGH 2015* ($ BILLION)
TABLE 46 GLOBAL MARKET FOR VACCINES BY GEOGRAPHICAL SEGMENT, THROUGH 2015 ($ BILLION)
FIGURE 24 GLOBAL MARKET FOR VACCINES SEGMENTED BY GEOGRAPHY, 2009-2015 (%)

Chapter-11: NUCLEIC ACIDS
GENERAL DESCRIPTION AND PROPERTIES
APPLICATIONS
THERAPEUTIC APPLICATIONS
Gene Therapies
Gendicine
Macugen
Oncorine
Vitravene
Gene Therapy Pipeline
DNA Vaccines
DIAGNOSTICS
DNA/RNA Biosensors
RNAi Diagnostics
RESEARCH
DNA Microarrays
RNAi Reagents
RECENT TECHNOLOGY DEVELOPMENTS
NANOGAP SENSOR ARRAY
PORTABLE DNA SENSOR
INDUSTRY STRUCTURE
TABLE 47 SELECTED SUPPLIERS OF NUCLEIC ACID-BASED MEDICAL APPLICATIONS
MARKET SIZE AND SEGMENTATION
TABLE 48 GLOBAL MEDICAL MARKET FOR NUCLEIC ACIDS BY APPLICATION SEGMENT, THROUGH 2015 ($ BILLION)
FIGURE 25 GLOBAL MEDICAL MARKET FOR NUCLEIC ACIDS BY APPLICATION SEGMENT, 2009-2015 (%)
TABLE 49 GLOBAL MARKET FOR NUCLEIC ACIDS BY GEOGRAPHICAL SEGMENT, THROUGH 2015 ($ BILLION)
FIGURE 26 GLOBAL MARKET FOR NUCLEIC ACIDS SEGMENTED BY GEOGRAPHY, 2009-2015 (%)

Chapter-12: MICROORGANISM
GENERAL DESCRIPTION AND PROPERTIES
APPLICATIONS
THERAPEUTIC
Probiotics
DRUG MANUFACTURING
INDUSTRY STRUCTURE
TABLE 50 SELECTED SUPPLIERS OF THERAPEUTIC PROBIOTICS
RECENT DEVELOPMENTS
NEW COATING TECHNIQUES
MARKET SIZE AND SEGMENTATION
TABLE 51 GLOBAL MARKET FOR PROBIOTICS, THROUGH 2015 ($ BILLION)
TABLE 52 GLOBAL MARKET FOR PROBIOTICS BY GEOGRAPHICAL SEGMENT, THROUGH 2015 ($ BILLION)
FIGURE 27 GLOBAL MARKET FOR PROBIOTICS SEGMENTED BY GEOGRAPHY, THROUGH 2015 (%)

Chapter-13: NON-STEM CELLS/TISSUES
GENERAL DESCRIPTION AND PROPERTIES
APPLICATIONS
RESEARCH
Cell-Based Assays
Tissue Microarrays
THERAPY
Cell Therapy
Tissue Engineered Products
DIAGNOSTIC APPLICATIONS
Cell-Based Biosensors
RECENT DEVELOPMENTS
VIRAL-MEDIATED GENE DELIVERY FOR CELL-BASED ASSAYS IN DRUG DISCOVERY
USE OF ARTIFICIAL INTELLIGENCE IN TISSUE MICROARRAY INTERPRETATION
HELPER T CELL’S EFFECT RAISES POSSIBILITY OF NEW CELLULAR THERAPY
SELF-ASSEMBLING MATERIALS FOR TISSUE ENGINEERING
NANOTECHNOLOGY-BASED APPROACHES TO TISSUE ENGINEERING
INDUSTRY STRUCTURE
TABLE 53 COMPANIES THAT SUPPLY OR ARE DEVELOPING CELL- AND TISSUE-BASED BIOTECHNOLOGIES
MARKET
TABLE 54 GLOBAL MARKET FOR NON-STEM CELL AND TISSUE-BASED BIOTECHNOLOGIES, 2009 THROUGH 2015 ($ BILLION)
FIGURE 28 TISSUE ENGINEERED PRODUCT MARKET, 2009 (%)
TABLE 55 GLOBAL MARKET FOR NON-STEM CELL- AND TISSUE BASED BIOTECHNOLOGIES BY GEOGRAPHICAL SEGMENT, THROUGH 2015 ($ BILLION)
FIGURE 29 GLOBAL MARKET FOR NON-STEM CELL AND TISSUE BASED BIOTECHNOLOGIES SEGMENTED BY GEOGRAPHY, THROUGH 2015 (%)

Chapter-14: BIOPOLYMERS
GENERAL DESCRIPTION AND PROPERTIES
TABLE 56 BIOPOLYMERS USED IN MEDICAL APPLICATIONS
POLYHYDROXYALKANOATES
POLYLACTIC ACID
COLLAGEN
CHITIN/CHITOSAN
HYALURONIC ACID
MEDICAL APPLICATIONS OF BIOPOLYMERS
THERAPEUTICS
Viscosupplementation
MEDICAL DEVICES
TABLE 57 MEDICAL DEVICE APPLICATIONS OF BIOPOLYMERS
Drug Delivery Devices
Orthopedic Devices
Scaffold Material for New Cartilage Formation
Contact/Intraocular Lenses
Cardiovascular Repair Devices
Miscellaneous Applications
MEDICAL AND SURGICAL SUPPLIES
TABLE 58 PRINCIPAL TYPES OF MEDICAL AND SURGICAL SUPPLIES FABRICATED FROM BIOPOLYMERS
Surgical Sutures
Ophthalmosurgical Products
Wound Care Products
RECENT DEVELOPMENTS IN BIOPOLYMERS
NEW APPLICATIONS
CUSTOMIZED BIOPOLYMERS
BIOPOLYMERS INDUSTRY STRUCTURE
TABLE 59 BIOPOLYMER SUPPLIERS
MARKET SIZE AND SEGMENTATION, 2009 THROUGH 2015
TABLE 60 GLOBAL MARKET FOR BIOPOLYMERS USED IN MEDICAL APPLICATIONS, THROUGH 2015 ($ BILLION)
FIGURE 30 GLOBAL MARKET FOR MEDICAL BIOPOLYMERS SEGMENTED BY TYPE OF APPLICATION, 2009-2015 (%)
TABLE 61 GLOBAL MARKET FOR MEDICAL BIOPOLYMERS BY TYPE OF POLYMER, THROUGH 2015 ($ BILLION)
FIGURE 31 GLOBAL MARKET FOR MEDICAL BIOPOLYMERS SEGMENTED BY TYPE OF BIOPOLYMER, 2009-2015 (%)
TABLE 62 GLOBAL MARKET FOR BIOPOLYMERS BY GEOGRAPHICAL SEGMENT, THROUGH 2015 ($ BILLION)
FIGURE 32 GLOBAL MARKET FOR MEDICAL BIOPOLYMERS SEGMENTED BY GEOGRAPHY, 2009-2015 (%)

Chapter-15: OTHER BIOMATERIALS
GENERAL DESCRIPTION AND PROPERTIES
BIOCOMPOSITES
BIOCERAMICS
MEDICAL APPLICATIONS
MEDICAL DEVICES
Bone Implants
Bone Cement
Orthopedic Device Coatings
Orbital Implants
Stents
RECENT DEVELOPMENTS
NANOPARTICULATE HYDROXYAPATITE
SYNTHETIC HYDROXYAPATITE SUBSTITUTES
NEW HA THIN FILM DEPOSITION METHODS
Electrophoretic Deposition
Pulsed Laser Deposition
NEW BIOCOMPOSITES
Nano-Reinforced PLA
Hydroxyapatite/Polymer Coatings
INDUSTRY STRUCTURE
TABLE 63 SUPPLIERS OF BIOCERAMICS AND BIOCOMPOSITES FOR MEDICAL APPLICATIONS
MARKET SIZE AND SEGMENTATION, 2009 THROUGH 2015
TABLE 64 GLOBAL MEDICAL MARKET FOR OTHER TYPES OF BIOMATERIALS, THROUGH 2015 ($ BILLION)
TABLE 65 GLOBAL MEDICAL MARKET FOR OTHER TYPES OF BIOMATERIALS BY TYPE OF MATERIAL, THROUGH 2015 ($ BILLION)
TABLE 66 GLOBAL MEDICAL MARKET FOR OTHER TYPES OF BIOMATERIALS BY END USE, THROUGH 2015 ($ BILLION)
TABLE 67 GLOBAL MARKET FOR OTHER BIOMATERIALS BY COUNTRY/REGION, THROUGH 2015 ($ BILLION)
FIGURE 33 GLOBAL MARKET FOR OTHER BIOMATERIALS SEGMENTED BY GEOGRAPHY, THROUGH 2015 (%)

Chapter-16: BIOELECTRONICS
GENERAL DESCRIPTION AND PROPERTIES
MEDICAL APPLICATIONS OF BIOELECTRONICS
BIOELECTRONIC SENSORS
Single-Site Bioelectronic Sensors
Enzyme Biosensors
Affinity Biosensors
Biochips
HUMAN AREA NETWORKS
BIOMOLECULAR FUEL CELLS
RECENT DEVELOPMENTS IN BIOELECTRONICS
CANTILEVER BIOCHIP TRANSDUCER
CARBON NANOTUBE-BASED ELECTRONIC BIOCHIP
BIOELECTRONICS INDUSTRY STRUCTURE
TABLE 68 BIOELECTRONICS SUPPLIERS AND DEVELOPERS
FIGURE 34 SINGLE-SITE BIOELECTRONIC SENSOR MARKET SHARES, 2008 (%)
MARKET SIZE AND SEGMENTATION, 2009 THROUGH 2015
TABLE 69 GLOBAL MARKET FOR BIOELECTRONICS USED IN MEDICAL APPLICATIONS, THROUGH 2015 ($ BILLION)
TABLE 70 GLOBAL MARKET FOR MEDICAL BIOELECTRONICS BY TYPE OF TECHNOLOGY, THROUGH 2015 ($ BILLION)
TABLE 71 GLOBAL MARKET FOR MEDICAL BIOELECTRONICS BY GEOGRAPHICAL SEGMENT, THROUGH 2015 ($ BILLION)
FIGURE 35 GLOBAL MARKET FOR MEDICAL BIOELECTRONICS SEGMENTED BY GEOGRAPHY, THROUGH 2015 (%)

Chapter-17: COMPANY PROFILES
AASTROM BIOSCIENCES, INC.
ABBOTT LABORATORIES, INC.
ADVANCED MEDICAL OPTICS, INC.
AJ EBIOCHIP GMBH
AJINOMOTO CO. INC.
AKERMIN, INC.
AMANO ENZYME INC.
AMGEN
ANTIGENICS INC.
ASURAGEN, INC.
AVEO PHARMACEUTICALS, INC.
BERKELEY ADVANCED BIOMATERIALS, INC.
BIOCATALYSTS LTD.
BIOLEX THERAPEUTICS, INC.
BIOMET, INC.
CANGENE
CARDIO POLYMERS
CARDIUM THERAPEUTICS
CELLULAR DYNAMICS INTERNATIONAL
CEQUENT PHARMACEUTICALS
CEREPLAST, INC.
CHIRALVISION BV
CSL BEHRING
FRIADENT GMBH
DEVRO MEDICAL LTD.
DHARMACON, INC.
DIATEC MONOCLONALS AS
DNA THERAPEUTICS SA
DURECT CORP.
ENZYSOURCE, INC.
EPITOMICS
EXCELIMMUNE, INC.
EYETECH PHARMACEUTICALS, INC.
GENMAB AS
GENZYME CORP.
GW PHARMACEUTICALS
IMCLONE SYSTEMS
IMMUNOMEDICS, INC.
IMMUNOGEN
INFRAMAT CORP.
INOVIO BIOMEDICAL CORP.
INTEGRATED ORBITAL IMPLANTS, INC.
INTERPORE CROSS INTERNATIONAL
LIVING CELL TECHNOLOGIES
MEDAREX, INC.
MEDICAGO INC.
MEDIMMUNE LLC
METABOLIX, INC.
MICROMET, INC.
MIV THERAPEUTICS, INC.
MORPHOSYS AG
MUSCULOSKELETAL TRANSPLANT FOUNDATION
NANOMIX, INC.
OCTAPHARMA AG
ONCOMED PHARMACEUTICALS INC.
ORGANOGENESIS INC.
ORIGEN THERAPEUTICS
OSEL INC.
OSIRIS THERAPEUTICS, INC.
PDL BIOPHARMA INC.
TABLE 72 PRODUCTS USING ANTIBODY HUMANIZTION TECHNOLOGIES
PHYTOMEDICS, INC.
PHYTOPHARM PLC
PLANET BIOTECHNOLOGY, INC.
POWERZYME, INC.
PRIMEX EHF
PROTEOGENIX S.A.
QUARK PHARMACEUTICALS, INC.
SEMBIOSYS GENETICS INC.
SIEMENS AG
SYMPHOGEN A/S
THERATASE LTD.
TIANAN BIOLOGIC MATERIAL CO., LTD.
TOYOBO CO., LTD.
VENTRIA BIOSCIENCE
VICAL INC.
X-ZYME GMBH